Form 4 filed by Megna Michael R
Megna Michael R filed this Form 4 on KNSA (Kiniksa Pharmaceuticals International, plc) with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:26:05 UTC.
- Accession
- 0001464583-26-000010
- Filer
- CIK 1464583
- Filed
- 2026-11-03
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: KNSA · Kiniksa Pharmaceuticals International, plc (CIK 1730430)
- Megna Michael R officer (CHIEF ACCOUNTING OFFICER)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Class A Ordinary Share | 2026-10-30 | M exercised | +4,689 | $10.76 | 33,751 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +3,932 | $11.1 | 37,683 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +7,209 | $11.97 | 44,892 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +4,065 | $17.76 | 48,957 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -6,030 | $91.87 | 42,927 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -6,831 | $92.77 | 36,096 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -9,508 | $94.2 | 26,588 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -3,705 | $94.86 | 22,883 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -3,145 | $96.08 | 19,738 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -1,691 | $97.11 | 18,047 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -5,350 | $97.74 | 12,697 | D |
| Share Option derivative | 2026-10-30 | M exercised | -3,932 | $0 | 0 | D |
| Share Option derivative | 2026-10-30 | M exercised | -7,209 | $0 | 0 | D |
| Share Option derivative | 2026-10-30 | M exercised | -4,689 | $0 | 2,983 | D |
| Share Option derivative | 2026-10-30 | M exercised | -4,065 | $0 | 16,394 | D |